Literature DB >> 11856276

Evaluation of the Rapid ID 32A system for identification of anaerobic Gram-negative bacilli, excluding the Bacteroides fragilis group.

Julie Downes1, Anna King, Jeremy Hardie, Ian Phillips.   

Abstract

OBJECTIVE: To evaluate the Rapid ID 32A system (bioMérieux, Marcy-l'Etoile, France) for the identification of anaerobic Gram-negative bacilli, excluding the Bacteroides fragilis group.
METHODS: Five hundred and twenty-eight identified clinical isolates of non-B. fragilis group anaerobic Gram-negative bacilli were tested in the Rapid ID 32A system, and identifications were compared with those obtained with conventional biochemical tests and gas-liquid chromatography.
RESULTS: The Rapid ID 32A system correctly identified 280 (60.9%) of the 460 isolates tested for which taxa were included in the database, without the need for additional testing. A further 97 (21.1%) isolates were correctly identified to species level following the performance of complementary tests recommended by the manufacturer. Fifty-nine (12.8%) isolates were identified at the genus level only, and 21 (4.6%) were misidentified at the species level. Three isolates of Prevotella were not identified by the system. Of the 68 isolates belonging to taxa not included in the database, no identification was obtained for 33 (48.5%), while 35 (51.5%) were misidentified.
CONCLUSIONS: The Rapid ID 32A system provided a rapid and reliable method for the identification of non-B. fragilis group, anaerobic Gram-negative bacilli to the genus level, while the success of species-level identification varied with different taxa. There was poor discrimination between Fusobacterium nucleatum and F. necrophorum, between Porphyromonas asaccharolytica and Porphyromonas endodontalis, and between Prevotella buccalis, Prevotella denticola, Prevotella loescheii, Prevotella melaninogenica and Prevotella oralis. The need to perform conventional complementary tests on 149 (32.4%) of the 460 isolates compromised the usefulness of the system for rapid species identification.

Entities:  

Year:  1999        PMID: 11856276     DOI: 10.1111/j.1469-0691.1999.tb00150.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  6 in total

1.  Species identification of clinical isolates of anaerobic bacteria: a comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems.

Authors:  Ulrik Stenz Justesen; Anette Holm; Elisa Knudsen; Line Bisgaard Andersen; Thøger Gorm Jensen; Michael Kemp; Marianne Nielsine Skov; Bente Gahrn-Hansen; Jens Kjølseth Møller
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

2.  Evaluation of the new Vitek 2 ANC card for identification of medically relevant anaerobic bacteria.

Authors:  Francine Mory; Corentine Alauzet; Céline Matuszeswski; Philippe Riegel; Alain Lozniewski
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

3.  16S rRNA gene sequencing in routine identification of anaerobic bacteria isolated from blood cultures.

Authors:  Ulrik Stenz Justesen; Marianne Nielsine Skov; Elisa Knudsen; Hanne Marie Holt; Per Søgaard; Tage Justesen
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

4.  Identification of clinically important anaerobic bacteria by an oligonucleotide array.

Authors:  Yu Tzu Lin; Mario Vaneechoutte; Ay Huey Huang; Lee Jene Teng; Hung-Mo Chen; Shu-Li Su; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2010-02-03       Impact factor: 5.948

5.  Evaluation of the Vitek 2 ANC card for identification of clinical isolates of anaerobic bacteria.

Authors:  E H L Lee; J E Degener; G W Welling; A C M Veloo
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

6.  Multicenter evaluation of the Vitek 2 anaerobe and Corynebacterium identification card.

Authors:  Robert P Rennie; Cheryl Brosnikoff; LeeAnn Turnbull; L Barth Reller; Stanley Mirrett; William Janda; Kathy Ristow; Ann Krilcich
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.